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Polytetrafluoroethylene (PTFE) Femorodistal Grafts with a Distal Vein 
Cuff for Critical Ischaemia 
L. D. Wijesinghe ~, D, M. Beardsmore and D, J. A. Scott 
Department of Vascular and Endovascular Surgery, St James's University Hospital, Leeds, U.K. 
Objective: To analyse the results of PTFE femorodistal bypass grafts using a distal anastomotic vein cuff in the treatment 
of critical ischaemia. 
Design: Prospective study of consecutive patients under the care of a single Vascular Surgeon. 
Setting: A dedicated Vascular Surgical Unit in a University teaching hospital. 
Subjects: Fifty-one consecutive f morodistal PTFE grafts were performed on 50 patients (median 74 years, range 58-94 
years, 25 men; median ankle:brachial index 0.4). In 28 (55%) a common ostium arteriovenous fistula (A VF) was fashioned 
at the distal anastomosis. 
Results: The 30-day postoperative mortality was 8%, with 10 (21%) major complications. The 1 and 2 year primary 
patency was 64% and 51%, respectively, with corresponding limb salvage rates of 85% and 80%. The presence of an 
A VF did not signi~'cantly affect graft patency or patient survival, but appeared to hinder limb salvage. The latter effect 
may be due to bias in patient selection. 
Conclusion: PTFE femorodistal grafts with a distal vein cuff are a suitable alternative to autogenous saphenous vein in 
distal reconstructions for critical ischaemia. No conclusions can be made about the efficacy of an A VF in this context. 
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Introduction 
Autogenous saphenous vein (ASV) has remained the 
conduit of choice for arterial bypasses in the leg since 
its introduction by Kunlin in 1949,1 and in its absence, 
arm vein achieves atisfactory patency rates. 2When 
no suitable venous conduit is available, a prosthetic 
graft such as PTFE is an alternative. While the patency 
rates for PTFE grafts to the above-knee popliteal artery 
compare favourably with those for ASV grafts, 3the 
same cannot be said for more distal bypasses, espe- 
cially those required for critical ischaemia or limb 
salvage surgery. 3'4 
Several arguments have been proposed to explain 
the lower patency rates of prosthetic grafts, including 
the higher flow rates required to prevent hrombosis 
in PTFE, 5 progression of more distal disease 6'7 and the 
development of neointimal hyperplasia t the distal 
anastomosis. 8"9 The effect of the latter may be mitigated 
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by the incorporation of a vein cuff at the distal ana- 
stomosis of a PTFE graft. 
A randomised study by the Joint Vascular Research 
Group 1° has shown no difference in patency rates 
between cuffed and uncuffed PTFE bypasses to the 
above-knee popliteal artery. However, in the below- 
knee position the cuffed grafts achieved asignificantly 
better patency rate. The number of distal bypasses in 
the trial was too small to allow meaningful analysis, 
but it would seem reasonable to assume that the 
beneficial effect of the vein cuff would extend to the 
smaller tibial and peroneal arteries where a direct 
PTFE to vessel anastomosis  technically more dif- 
ficult. Raptis and Miller support his hypothesis with 
a 12-month patency of 80% for primary femorodistal 
PTFE grafts with cuffs for limb threatening ischaemia. 11 
This figure was significantly better than the patency 
of uncuffed istal grafts. 
This paper reports the results of femorodistal PTFE 
grafts covering a mixture of primary, secondary and 
tertiary procedures in which no suitable venous con- 
duit was available. All bypasses were carried out for 
critical ischaemia s defined by the Second European 
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Table 1. Distribution of risk factors according to ISCVS/SVS 
criteria. 
Risk factor Number of patients 
(%) 
Cardiac status 
0 Asymptomatic, normal ECG 25 (50) 
1 Asymptomatic, remote or occult MI 10 (20) 
2 Stable angina, controlled ectopy 11 (22) 
3 Unstable angina, symptomatic e topy, 4 (8) 
MI<6 months ago 
Diabetes 
0 None 37 (74) 
1 Adult onset, diet controlled 9 (18) 
2 Adult onset, insulin controlled 4 (8) 
3 Juvenile onset 0 (0) 
Tobacco use 
0 None for last 10 years 34 (68) 
1 None current, smoked in last 10 years 3 (6) 
2 Current, less than one pack/day 11 (22) 
3 Current, more than one pack/day 2 (4) 
Hypertension 
0 None 38 (76) 
1 One-drug controlled 9 (18) 
2 Two-drug controlled 3 (6) 
3 Needs more than three drugs, uncontrolled 0 (0) 
Carotid disease 
0 No symptoms, no bruit 42 (84) 
1 Asymptomatic but with evidence of disease 1 (2) 
2 Transient ischaemic attack 5 (10) 
3 Stroke 2 (4) 
Hyperlipidaemia 
0 Cholesterol/triglycerides within normal 42 (84) 
limits 
1 Mild elevation, diet control 6 (12) 
2 Types IL III and IV, strict diet 0 (0) 
3 Diet and drug control 2 (4) 
Consensus Department 12 and were constructed with a 
distal anastomotic vein cuff. 
Patients and Methods 
Patient details 
Fifty-one consecutive femorodistal PTFE grafts were 
performed on 50 patients (median 74 years, range 
58-94 years, 25 men) between December 1993 and 
January 1996. All patients had critical ischaemia as 
defined by the European Consensus Document. ~2 
Thirty-seven (73%) had rest pain alone and 14 (27%) 
had a combination of rest pain and tissue loss. The 
median ankle:brachial pressure index at rest was 0.4 
(interquartile range 0.2-0.5) and the median isotope 
limb blood flow was 2.12 ml / 100 ml /min  (interquartile 
range 1.42-3.80), the low normal value being 10ml/  
100ml/min. ~3 Patients' risk factors were recorded pro- 
spectively according to ISCVS/SVS recommenda- 
tions ~4 and are detailed in Table 1. All patients were 
prescribed a daily dose of 75 mg aspirin and enrolled 
in a duplex graft surveillance programme. Patients 
noted to have been lost to follow-up were recalled for 
graft assessment. 
Operative details 
All procedures were carried out by a single Consultant 
Vascular Surgeon (DJAS) working in a dedicated Vas- 
cular Surgical Unit of a University teaching hospital. 
A standard technique was employed involving a com- 
bination of general and epidural anaesthetic. Broad- 
spectrum antibiotic cover was instituted at the in- 
duction of anaesthesia and continued for three post- 
operative doses. Five thousand units of heparin were 
administered intravenously before the application of 
vessel clamps. In all cases the graft used was 6ram 
diameter externally supported PTFE (Impra, Arizona, 
U.S.A.). Having tunnelled the graft, an exsanguinating 
Esmarch tourniquet was applied to allow a bloodless 
operating field at the distal anastomosis while avoiding 
the use of clamps on small calf vessels. A common 
ostium AVF was fashioned to a vena comitans of the 
recipient artery in cases where an incomplete pedal 
arch was seen on the preoperative angiogram. 
Statistical analysis 
Analysis was performed using the Statistica software 
package (StatSoft, Oklahoma, U.S.A.). Graft patency, 
patient survival and limb salvage were calculated by 
the life-table method. Comparisons between patient 
groups were made using the log-rank test. 
Results 
Ail patients previously lost to follow-up attended for 
Duplex scanning in response to a recall producing a 
100% follow up record. The median time of follow-up 
was 13 months, ranging from 6 to 36 months. Four 
patients died during the 30-day postoperative period, 
three from myocardial infarction and one from multi- 
organ failure. There were 10 (21%) major complications 
during the same period; three patients uffered myo- 
cardial infarction; three developed renal failure com- 
plicating preoperative renal impairment; there were 
two cases of secondary graft haemorrhage; one patient 
was successfully resuscitated from a bradycardiac ar- 
rest and there was one graft infection necessitating 
removal of the PTFE. 
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For the majority of grafts (46, 90%) the inflow vessel 
was the native common femoral artery. In three cases 
the distal end of a Dacron aorto-biprofunda graft 
served as inflow and in two cases the distal superficial 
femoral artery. The commonest outflow vessel was 
the anterior tibial artery (22, 43%), followed by the 
posterior tibial artery (19, 37%) and the peroneal artery 
(10, 20%). Five grafts (9%) took an extra-anatomical 
course via lateral thigh and lateral Side of the knee 
joint to reach the anterior tibial artery. Twenty-four 
grafts (47%) were primary PTFE grafts in patients 
whose arm and leg veins were of insufficient size, 
inadequate quality, or had been used for coronary 
bypass. Twenty-three grafts (45%) were secondary and 
four (8%) tertiary. 
Of those patients who survived to 30 days (46, 92%) 
all had a graft scan at 1 month. Of those 35 who 
survived a year, 32 (91%) attended for their 12 month 
scan and of the 16 patients who survived to 2 years, 
15 (94%) were scanned. A graft was deemed to be at 
risk of occluding if there was a doubling of the peak 
systolic velocity or if the velocity fell below 40 cm/s. 
During follow-up, 11 grafts (22%) were reported to be 
at risk for the following reasons: five had low velocities 
due to run-off disease; two had low velocities due to 
inflow disease in the external iliac artery; two had 
low velocities for no identifiable reason and two had 
significant stenoses just proximal to the vein cuff. The 
at risk grafts underwent digital subtraction angio- 
graphy which agreed with the findings of Duplex in 
all cases. Significant stenoses were treated by balloon 
angioplasty. Two of the five run-off lesions recurred 
within 3 months of angioplasty and have needed 
repeat procedures, two remain non-significant and one 
graft occluded, but was re-opened by thrombolysis 
and angioplasty. Unfortunately the graft failed again 
and the patient underwent above-knee amputation. 
Neither of the inflow lesions has recurred. Both grafts 
which had low velocity flow with no identifiable cause 
subsequently occluded and could not be rescued. In 
the two cases where a stenosis was found proximal to 
the cuff, angiography confirmed that the lesion was 
confluent with the heel of the PTFE to cuff anastomosis. 
One of these lesions remains non-significant after bal- 
loon angioplasty, but the second recurred after 4 
months and was successfully treated by vein patch 
angioplasty. 
The 1 and 2-year primary patency rates were 64% 
and 51%, respectively (Fig. 1), compared with sec- 
ondary patency rates for the same periods of 66% and 
52%. Limb salvage figures at 1 and 2 years were 85% 
and 80%, respectively (Fig. 2), and patient suvival at 
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Fig. 1. Kaplan-Meier plot of primary patency. Numbers at risk are 
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Fig. 2. Kaplan-Meier plot of limb salvage. Numbers at risk are 
shown adjacent to the line. 
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Fig. 3. Kaplan-Meier plot of patient survival. Numbers at risk are 
shown adjacent to the line. 
diabetes, smoking history, ischaemic heart disease and 
primary or secondary surgery appeared to have no 
significant effect on graft patency, limb salvage or 
survival (Table 2). 
A distal AVF was constructed in 28 (55%) grafts and 
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Table 2. Comparison of graft patency, limb salvage and survival according to 
selected criteria. 
p value (log rank test) 
Patency Limb salvage Survival 
Primary vs. secondary 0.92 
operation 
Diabetic vs. not diabetic 0.27 
Smoker vs. non smoker 0.31 
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Fig. 4. Kaplan-Meier plot of limb salvage for patients with (+ AVF) 
and without (-AVF) a distal arteriovenous fi tula. The difference 
between the groups is significant (p= 0.02) by the log-rank test. (--) 
+AVF; (--) -AVE 
comparison was made between the AVF and non-AVF 
groups with respect o graft patency, limb salvage and 
patient survival. There was no significant difference 
between the groups as far as graft patency (p = 0:96) 
and survival (p = 0.64) were concerned, but limb sal- 
vage appeared to be favoured by the absence of an 
AVF (p=0.02) (Fig. 4). 
Four patients required a major amputation during 
the follow-up period; two below-knee amputations 
at 1 and 3 days after bypass, and two above-knee 
amputations at 5 and 15 months. The amputations 
followed a primary bypass operation in one case, a 
secondary in two and a tertiary in one. 
Discussion 
Femorodistal arterial reconstruction i the absence of 
autologous vein presents a challenge to both vascular 
surgeon and patient. There are some who, in the past, 
have disputed the wisdom of performing a PTFE 
bypass in these circumstances and have supported a
policy of primary amputation. Is However, within the 
confines of surgery for critical ischaemia, our primary 
patency rates of 64% at 1 year and 51% at 2 years lend 
support o the view that PTFE with a distal vein cuff 
can be used successfully in pr imary and subsequent 
femorodistal bypasses if autologous vein is not avail- 
able. Our patency rates compare favourably with other 
series of cuffed grafts. Morris reported a 1-year patency 
of 51% for primary grafts and 44% for secondary and 
subsequent bypasses; ~6 and Raptis reported 1 and 2- 
year patencies of 81% and 60%, respectively, for prim- 
ary grafts, n The patency rates of uncuffed PTFE femo- 
rodistal grafts may approach our figures, 3'4 but we 
remain convinced of the advantages of the vein cuff 
in assisting a technically better anastomosis, par- 
ticulary to small vessels, and in preserving the outflow 
in the event of graft thrombosis, n'17. 
The graft surveillance programme was able to 
identify 11 at risk grafts, of which eight remain patent 
with the help of balloon angioplasty or a vein patch. 
Clearly angioplasty of inflow, peri-cuff or outflow 
lesions can extend the life of a failing PTFE graft, 
and this would be a strong argument in favour of 
continuing the programme although a formal cost 
benefit analysis is yet to be performed. 
The secondary patency at 2 years was 52%, and the 
limb salvage rate at the same time was 80%. This 
difference has been noted before; 3-year patency 43% 
and limb salvage 71%, 4 4-year patency 38% and limb 
salvage 70°/o, 3 and may relate to a combination of 
periarterial sympathectomy performed uring vessel 
dissection; and muscle adaptation and formation of 
collaterals during the time of a failing graft. 
The absence of a difference in patency, limb salvage 
or survival between smokers and non-smokers, and 
diabetics and non-diabetics, is interesting. The rel- 
atively small numbers of patients in each group (13 
diabetics, 16 smokers) may explain the failure to detect 
a difference if there is one. 
The concept of using an AVF to save ischaemic limbs 
was first conceived in 1902,18 and its beneficial effects 
on microcirculatory haemodynamics, graft patency 
and limb salvage have been demonstrated. 19 Harris et 
aI. 2° suggest hat the patency of prosthetic grafts with 
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an ad juvant  AVF and ve in  cuff is super ior  to that of 
similar grafts wi th  AVF alone. However ,  we have not  
been able to demonstrate  that the AVF confers any 
advantage when l inked with  a ve in  cuff. Our  data 
appear to show a detr imenta l  effect of AVFs on l imb 
salvage. This may s imply  be a reflection of the more 
extensive disease in pat ients who were selected to 
have an AVF, because they had an absent pedal  arch 
on angiography.  Patients were not  randomised  to have 
an AVF, so a mean ingfu l  assessment of the role of 
AVFs cannot  be made. 
This s tudy indicates that femorodistal  PTFE grafts 
have an acceptable patency and l imb salvage rate 
when used in combinat ion  with a distal ve in  cuff for 
pat ients wi th  l imb-threatening ischaemia. No proof of 
super ior i ty over an uncuf fed graft can be inferred, but  
evidence from the Joint Vascular Research Group is 
compel l ing,  at least for be low-knee bypasses. The role 
of an ad juvant  AVF may not  be clarified wi thout  
recourse to a randomised  trial. 
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